I agree that this site is using cookies. You can find further informations here.
X
Mishra, Rosalin
52  results:
Search for persons X
?
1

HER3 V104 mutations regulate cell signaling, growth, and dr..:

Mishra, Rosalin ; Kilroy, Mary Kate ; Feroz, Wasim..
Molecular Carcinogenesis.  63 (2024)  8 - p. 1528-1541 , 2024
Link: https://doi.org/10.1002/..
 
?
2

RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits ..:

Patel, Hima ; Mishra, Rosalin ; Wier, Adam...
Anti-Cancer Drugs.  34 (2023)  4 - p. 519-531 , 2023
Link: https://doi.org/10.1097/..
 
?
3

HER2 inhibition increases non-muscle myosin IIA to promote ..:

Alanazi, Samar M. ; Feroz, Wasim ; Mishra, Rosalin...
PLOS ONE.  18 (2023)  5 - p. e0285251 , 2023
Link: https://doi.org/10.1371/..
 
?
4

HER3 Alterations in Cancer and Potential Clinical Implicati..:

Kilroy, Mary Kate ; Park, SoYoung ; Feroz, Wasim...
Cancers.  14 (2022)  24 - p. 6174 , 2022
Link: https://doi.org/10.3390/..
 
?
5

PI3K Inhibitors in Cancer: Clinical Implications and Advers..:

Mishra, Rosalin ; Patel, Hima ; Alanazi, Samar..
International Journal of Molecular Sciences.  22 (2021)  7 - p. 3464 , 2021
Link: https://doi.org/10.3390/..
 
?
6

IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in ..:

Patel, Hima ; Mishra, Rosalin ; Yacoub, Nour...
Cancers.  13 (2021)  22 - p. 5863 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (R..:

Mishra, Rosalin ; Yuan, Long ; Patel, Hima...
International Journal of Molecular Sciences.  22 (2021)  4 - p. 2088 , 2021
Link: https://doi.org/10.3390/..
 
?
8

BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dep..:

Yuan, Long ; Mishra, Rosalin ; Patel, Hima...
Cancers.  12 (2020)  6 - p. 1661 , 2020
Link: https://doi.org/10.3390/..
 
?
9

Current Advances in the Treatment of BRAF-Mutant Melanoma:

Patel, Hima ; Yacoub, Nour ; Mishra, Rosalin...
Cancers.  12 (2020)  2 - p. 482 , 2020
Link: https://doi.org/10.3390/..
 
?
10

Oxidative Cyclization‐Induced Activation of a Phosphoinosit..:

Zhu, Haizhou ; Mishra, Rosalin ; Yuan, Long...
ChemMedChem.  14 (2019)  22 - p. 1933-1939 , 2019
Link: https://doi.org/10.1002/..
 
?
11

Utilization of Reactive Oxygen Species Targeted Therapy to ..:

Yuan, Long ; Mishra, Rosalin ; Patel, Hima...
Journal of Cancer.  9 (2018)  24 - p. 4665-4676 , 2018
Link: https://doi.org/10.7150/..
 
?
12

HER3 signaling and targeted therapy in cancer:

Mishra, Rosalin ; Patel, Hima ; Alanazi, Samar..
Oncology Reviews.  , 2018
Link: https://doi.org/10.4081/..
 
?
13

Activating HER3 mutations in breast cancer:

Mishra, Rosalin ; Alanazi, Samar ; Yuan, Long...
Oncotarget.  9 (2018)  45 - p. 27773-27788 , 2018
Link: https://doi.org/10.18632..
 
?
14

Genomic alterations of ERBB receptors in cancer: clinical i..:

Mishra, Rosalin ; Hanker, Ariella B. ; Garrett, Joan T.
Oncotarget.  8 (2017)  69 - p. 114371-114392 , 2017
Link: https://doi.org/10.18632..
 
?
15

Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mic..:

Chakraborty, Goutam ; Kumar, Santosh ; Mishra, Rosalin...
PLoS ONE.  7 (2012)  3 - p. e33633 , 2012
Link: https://doi.org/10.1371/..
 
1-15